Unregulated products can vary in purity and potency, increasing the risk of contamination or incorrect dosing
Non-FDA-approved compounded incretin products are not recommended for use due to uncertainty about their content and resulting concerns about safety, quality, and effectiveness
Others want nothing to do with needles, prescriptions, or the gastrointestinal side effects that come with pharmaceutical doses
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide (October 17, 2024) Tirzepatide And Muscle Composition Changes In People With Type 2 Diabetes (SURPASS-3 MRI): A Post-Hoc Analysis Of A Randomised, Open-Label, Parallel-Group, Phase 3 Trial (April 30, 2025) Changes In Lean Body Mass With Glucagon-Like Peptide-1-Based Therapies And Mitigation Strategies (June 27, 2024) Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (July 8, 2025) WEGOVY (semaglutide) Prescribing Information (November 2024)
Promotional offers like "$200 off Tirzepatide" or "50% off first order" are time-limited and may not be available when you visit the website
I was success maintaining my weight for 10 years